cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.30009331
title: Evaluating ChatGPT’s Multilingual Performance in Clinical Nutrition Advice Using Synthetic Medical Text: Insights from Central Asia

description: This dataset comprises ChatGPT-generated nutritional recommendations and sample diet plans for 50 distinct patient profiles. Each case study represents the patient profile with sociocultural background of ethnic groups in Central Asia and provides comprehensive data on age, gender, cultural and medical history, dietary patterns, anthropometric characteristics, disease-related functional indicators, biochemical and hematological parameters, and lifestyle behaviors. The LLM outputs include general nutritional recommendations and individualized daily meal plans based on Central Asian foods for each profile. At the same time, we are providing codes for translation into local languages.In case of using our dataset, please cite our work: Adilmetova, G., Nassyrov, R., Meyerbekova, A., Karabay, A., Varol, H. A., & Chan, M. Y. (2025). Evaluating ChatGPT's Multilingual Performance in Clinical Nutrition Advice Using Synthetic Medical Text: Insights from Central Asia. The Journal of nutrition, 155(3), 729–735. https://doi.org/10.1016/j.tjnut.2024.12.018
DOI: 10.6084/m9.figshare.30009331.v3
title: Evaluating ChatGPT’s Multilingual Performance in Clinical Nutrition Advice Using Synthetic Medical Text: Insights from Central Asia

description: This dataset comprises ChatGPT-generated nutritional recommendations and sample diet plans for 50 distinct patient profiles. Each case study represents the patient profile with sociocultural background of ethnic groups in Central Asia and provides comprehensive data on age, gender, cultural and medical history, dietary patterns, anthropometric characteristics, disease-related functional indicators, biochemical and hematological parameters, and lifestyle behaviors. The LLM outputs include general nutritional recommendations and individualized daily meal plans based on Central Asian foods for each profile. At the same time, we are providing codes for translation into local languages.In case of using our dataset, please cite our work: Adilmetova, G., Nassyrov, R., Meyerbekova, A., Karabay, A., Varol, H. A., & Chan, M. Y. (2025). Evaluating ChatGPT's Multilingual Performance in Clinical Nutrition Advice Using Synthetic Medical Text: Insights from Central Asia. The Journal of nutrition, 155(3), 729–735. https://doi.org/10.1016/j.tjnut.2024.12.018
DOI: 10.6084/m9.figshare.30009331.v2
title: Evaluating ChatGPT’s Multilingual Performance in Clinical Nutrition Advice Using Synthetic Medical Text: Insights from Central Asia

description: This dataset comprises ChatGPT-generated nutritional recommendations and sample diet plans for 50 distinct patient profiles. Each case study represents the patient profile with sociocultural background of ethnic groups in Central Asia and provides comprehensive data on age, gender, cultural and medical history, dietary patterns, anthropometric characteristics, disease-related functional indicators, biochemical and hematological parameters, and lifestyle behaviors. The LLM outputs include general nutritional recommendations and individualized daily meal plans based on Central Asian foods for each profile. At the same time, we are providing codes for translation into local languages.In case of using our dataset, please cite our work: Adilmetova, G., Nassyrov, R., Meyerbekova, A., Karabay, A., Varol, H. A., & Chan, M. Y. (2025). Evaluating ChatGPT's Multilingual Performance in Clinical Nutrition Advice Using Synthetic Medical Text: Insights from Central Asia. The Journal of nutrition, 155(3), 729–735. https://doi.org/10.1016/j.tjnut.2024.12.018
DOI: 10.15468/dl.k45d9f
title: Occurrence Download

description: A dataset containing 121990 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is Specimen",
 "Continent is Africa",
 "DatasetKey is Royal Botanic Gardens, Kew - Herbarium Specimens",
 "OccurrenceStatus is Present",
 "TaxonKey is Poaceae"
 ]
}

 The dataset includes 121990 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0003641-260126135527185/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/pr00012699
title: A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination With Ipilimumab or Nivolumab Monotherapy in Participants With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

description: The purpose of this study is to demonstrate the clinical activity of nivolumab in combination with ipilimumab in multiple types of tumors based on their Tumor Mutational Burden status.
DOI: 10.25934/pr00012700
title: A Single-Arm Phase 2 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Squamous Cell Non-Small Cell Lung Cancer Who Have Received At Least Two Prior Systemic Regimens

description: The purpose of the study is to assess the objective response rate (change in tumor size from baseline) in patients with advanced or metastatic squamous cell nonsmall-cell lung cancer treated with Nivolumab (BMS-936558) after failure of 2 prior systemic regimens
DOI: 10.25934/pr00012701
title: A Multi-arm Phase I Safety Study of Nivolumab in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)

description: * The study is evaluating the safety and tolerability of Nivolumab (BMS-936558) when combined with three platinum-based doublet chemotherapy regimens (Cisplatin/Gemcitabine; Cisplatin/Pemetrexed; and Carboplatin/Paclitaxel) in subjects with NSCLC.* The study is evaluating the safety and tolerability of Nivolumab as maintenance therapy in combination with Bevacizumab/Avastin that will be given after at least 4 cycles of platinum doublet chemotherapy.* The study is evaluating the safety and tolerability of Nivolumab in combination with Erlotinib among epidermal growth factor receptor (EGFR) mutation positive non-squamous NSCLC subjects and as monotherapy in subjects with NSCLC.* The study is evaluating the safety and tolerability of Nivolumab in combination with Ipilimumab in subjects with squamous and non-squamous NSCLC.* The study is evaluating the safety and tolerability of Nivolumab as switch maintenance therapy in subjects with squamous and non-squamous NSCLC.* The study is evaluating the safety and tolerability of Nivolumab as monotherapy among subjects with untreated, asymptomatic brain metastases and no evidence of cerebral edema.
DOI: 10.25934/pr00012702
title: A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody

description: The purpose of this study is to determine the rate and frequency of high-grade (CTCAE v4.0 Grade 3 or higher), treatment-related, select adverse events in subjects with histologically confirmed stage III (unresectable) or stage IV melanoma and progression post prior treatment containing an anti-Cytotoxic T Lymphocyte Antigen (CTLA-4) monoclonal antibody, treated with Nivolumab (BMS-936558) at a dose of 3 mg/kg every two weeks.
DOI: 10.15468/dl.j7v868
title: Occurrence Download

description: A dataset containing 13919499 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is ICES DATRAS Surveys"
 ]
}

 The dataset includes 13919499 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0003613-260126135527185/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/pr00012703
title: A Phase 3b/4 Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Renal Cell Carcinoma (CheckMate 374: CHECKpoint Pathway and Nivolumab Clinical Trial Evaluation 374)

description: This study will generate safety data on Nivolumab given by itself in treatment of advanced Renal Cell Carcinoma (RCC). The primary objective of this study is to assess immune related side effects, also known as immune-mediated adverse events (IMAEs), in patients treated with Nivolumab.
DOI: 10.5061/dryad.w0vt4b8z7
title: Rapid and reversible humidity-dependent colour change by water film formation in a scaled springtail: Image compilations and video recordings

description: Colour is often not a static trait but can change over time either through
 biotic or abiotic factors.  Humidity-dependent colour change can
 occur through either morphological change (e.g. to feather barbules in
 birds) or by the replacement of air by water causing a shift in refractive
 index, as seen in arthropod multilayer cuticles or scales. The scaled
 springtail Lepidocyrtus cyaneus has scales that produce color largely via
 thin film interference from their lamina. We observed a marked colour
 change from golden to violet/purple colouration in humid conditions. Light
 microscopy, microspectrophotometry, contact angle goniometry and optical
 modelling indicate that the formation of a thin film of water on top of
 the hydrophilic scales increases their laminar thin film thickness,
 causing a shift towards violet/purple colour. Evaporation of the water
 film causes the metallic golden colour to return. This constitutes a
 remarkably rapid colour change (in the order of seconds), only limited by
 the speed of water film condensation and evaporation, that may serve as
 inspiration for new dynamically coloured materials and sensors.
description: # Rapid and reversible humidity-dependent colour change by water film
 formation in a scaled springtail: Image compilations and video recordings
 [https://doi.org/10.5061/dryad.w0vt4b8z7](https://doi.org/10.5061/dryad.w0vt4b8z7) The dataset consists of a series of image compilation videos or video recordings that show the humidity-dependent colour change of body scales of the springtail *L. cyaneus,* showing a clear colour plasticity between golden and violet/blue during a wetting (through misting) and drying process. Video 2a constitutes a screen recording using a cell phone of a live feed of the microspectrophotometer while 2b consists of a video of a live feed recorded by the integrated Pixelink software. Two videos show the contact angle goniometry method.
DOI: 10.25934/pr00012704
title: A Phase IIIb/IV Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen

description: The purpose of this study is to estimate the incidence and characterize the outcome of high grade, select adverse events in subjects with advanced or metastatic NSCLC treated with Nivolumab.
DOI: 10.25934/pr00012705
title: A Randomized, Blinded, Phase 2 Dose-Ranging Study Of BMS-936558 (MDX-1106) In Subjects With Progressive, Advanced/Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy

description: The purpose of this study is to measure how active BMS-936558 (nivolumab) is against Renal Cell Carcinoma (RCC) as measured by the disease not progressing and whether a dose response relationship exists.
DOI: 10.25934/pr00012706
title: A Phase 1/2, Dose-escalation, Open-label, Non-comparative Study of Nivolumab or Nivolumab in Combination With Ipilimumab in Advanced Hepatocellular Carcinoma Subjects With or Without Chronic Viral Hepatitis; and a Randomized, Open-label Study of Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Subjects Who Are Naive to Systemic Therapy

description: The first part of the study is the Dose Escalation Phase designed to establish the safety of nivolumab at different dose levels for each of the three cohorts (uninfected hepatocellular carcinoma (HCC) subjects, hepatitis C virus (HCV)-infected HCC subjects, and hepatitis B virus (HBV)-infected subjects).The second part of the study is the Expansion Phase designed to generate additional clinical data at specified doses for each of the 3 cohorts. A third cohort has been added in this study to compare the efficacy of nivolumab and sorafenib in the treatment of Advanced HCC. A fourth cohort will generate data on the safety and efficacy of the combination nivolumab plus ipilimumab in the treatment of Advanced HCC. In the fifth cohort, additional clinical data will be generated for Child-Pugh B subjects. A Cabozantinib Combination Cohort has been added to evaluate the safety and tolerability of nivolumab in combination with cabozantinib and nivolumab with ipilimumab in combination with cabozantinib.
DOI: 10.25934/pr00012707
title: A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab in Subjects With Advanced or Metastatic Solid Tumors

description: To investigate the safety and efficacy of nivolumab as a single agent or in combination with ipilimumab in 6 tumor types - triple-negative breast cancer (TNBC), gastric cancer (GC), pancreatic adenocarcinoma (PC), small cell lung cancer (SCLC), bladder cancer (BC), and ovarian cancer (OC). A combination of nivolumab with ipilimumab and cobimetinib is also investigated in PC.
DOI: 10.25934/pr00012708
title: A Phase 3, Randomized Study of Adjuvant Immunotherapy With Nivolumab Combined With Ipilimumab Versus Nivolumab Monotherapy After Complete Resection of Stage IIIb/c/d or Stage IV Melanoma

description: The purpose of this study is to determine whether an investigational immunotherapy Nivolumab, when combined with Ipilimumab, is more effective than Nivolumab by itself, in delaying the return of cancer in patients who have had a complete surgical removal of stage IIIb/c/d or stage IV Melanoma
DOI: 10.25934/pr00012709
title: A Phase III, Randomized, Open Label Trial of Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma

description: The purpose of this study is to test the effectiveness and tolerability of the combination of Nivolumab and Ipilimumab compared to Pemetrexed and Cisplatin or Carboplatin in patients with unresectable pleural mesothelioma.
DOI: 10.5061/dryad.r7sqv9sjt
title: Sexually concordant selection on floral traits despite greater opportunity for selection through male fitness

description: Pollinators are important drivers of floral trait evolution, yet plant
 populations are not always perfectly adapted to their pollinators. Such
 apparent maladaptation may result from conflicting selection through male
 and female sexual functions in hermaphrodites. We studied sex-specific
 mating patterns and phenotypic selection on floral traits in Aconitum
 gymnandrum. After genotyping 1786 offspring, we partitioned individual
 fitness into sex-specific selfed and outcrossed components and estimated
 phenotypic selection acting through each. Relative fitness increased with
 increasing mate number, and more so for male function. This led to greater
 opportunity for selection through outcrossed male fitness, though patterns
 of phenotypic selection on floral traits tended to be similar, and with
 better support for selection through female rather than male fitness
 components. We detected directional selection through one or more fitness
 components for larger flower number, larger flowers, and more negative
 nectar gradients within inflorescences.  Our results are
 consistent with Bateman’s principles for sex-specific mating patterns and
 illustrate that, despite the expected difference in opportunity for
 selection, patterns of variation in selection across traits can be rather
 similar for the male and female sexual functions. These results shed new
 light on the effect of sexual selection on the evolution of floral traits.
description: # Sexually concordant selection on floral traits despite greater
 opportunity for selection through male fitness P\_ID: identity for each
 plant self\_rate: estimated selfing rate, ratio data with no dimension
 sirnum\_C\_P: sire number through outcrossing per plant, measured in
 number Re\_fit\_M\_C: relative male outcrossing fitness, ratio data with
 no dimension seeds\_T\_P: seeds produced per plant, measured in number
 Re\_fit\_Fe\_T: relative female total fitness, ratio data with no
 dimension F\_num: number of flowers, measured in number Me\_Galea: Mean
 Galea height, measured in mm Me\_nectar: mean nectar volume, measured in
 μL slop\_nectar: nectar gradients, coefficients and with no dimension
 mates\_male\_Fun\_T: number of mates they donate pollen, measured in
 number mates\_female\_Fun\_T: number of mates they received pollen,
 measured in number
DOI: 10.5061/dryad.905qftts0
title: Supplementary materials for: Striking cuticular hydrocarbon dimorphism in the mason wasp Odynerus spinipes and its possible evolutionary cause (Hymenoptera: Chrysididae, Vespidae)

description: Cleptoparasitic wasps and bees smuggle their eggs into the nest of a host
 organism. Here the larvae of the cleptoparasite feed upon the food
 provision intended for the offspring of the host. As cleptoparasitism
 incurs a loss of fitness for the host organism (offspring of the host fail
 to develop), hosts of cleptoparasites are expected to exploit cues that
 alert them to potential cleptoparasite infestation. Cuticular hydrocarbons
 (CHCs) could serve as such cues, as insects inevitably leave traces of
 them behind when entering a nest. By mimicking the host's CHC
 profile, cleptoparasites can conceal their presence and evade detection by
 their host. Previous studies have provided evidence of cleptoparasites
 mimicking their host's CHC profile. However, the impact of this
 strategy on the evolution of the host's CHC profile has remained
 unexplored. Here, we present results from our investigation of a
 host-cleptoparasite system consisting of a single mason wasp species that
 serves syntopically as the host to three cuckoo wasp species. We found
 that the spiny mason wasp (Odynerus spinipes) is able to express two
 substantially different CHC profiles, each of which is seemingly mimicked
 by a cleptoparasitic cuckoo wasp (i.e. Chrysis mediata and Pseudospinolia
 neglecta). The CHC profile of the third cuckoo wasp (Chrysis viridula), a
 species not expected to benefit from mimicking its host's CHC profile
 because of its particular oviposition strategy, differs from the two CHC
 profiles of its host. Our results corroborate the idea that the similarity
 of the CHC profiles between cleptoparasitic cuckoo wasps and their hosts
 is the result of chemical mimicry. They further suggest that
 cleptoparasites may represent a hitherto unappreciated force that drives
 the evolution of their hosts' CHCs.
description: # Supplementary Materials
 [https://doi.org/10.5061/dryad.905qftts0](https://doi.org/10.5061/dryad.905qftts0) ## Description of the data and file structure These are the supplementary materials referred to in the article 'Striking cuticular hydrocarbon dimorphism in the mason wasp *Odynerus spinipes* and its possible evolutionary cause (Hymenoptera: Chrysididae, Vespidae)' (Wurdack et al., 2015) [https://doi.org/10.1098/rspb.2015.1777](https://doi.org/10.1098/rspb.2015.1777) <br> <br> ## Sharing/Access information * ## Code/Software
DOI: 10.21223/p3/ywxfwm
title: Dataset for: Participatory Varietal Selection of 5 late blight resistant clones in the localities of 3 de Diciembre and Paca in Junin, Peru

description: The Mother and Baby (M&B) trial methodology was adapted by CIP for Participatory Variety Selection (PVS) through decentralized evaluation networks and multi-year evaluations in potato growing areas in the Andean region. The M&B trial design encourages active participation of farmers through the application of treatments through systematic evaluations and selections of treatments in their own plots called "Baby trials" (i.e. farmer managed trials) and in fields with an experimental design called "Mother trials" (i.e. researcher managed trials). Objective: Analyze characteristics, attributes and preferences that men and women have when selecting a new potato variety at the phase of flowering and harvesting. A M&B trial was performed to evaluate 5 clones with late blight resistance in the localities of 3 de Diciembre in the province of Chupaca, and the locality of Paca in the province of Jauja, in Junin department, Peru. The trial design was a Randomized Complete Block Design (RCBD) with 3 replicates for Mother trials and 3 replicates during the period 2013-2014. Total number of participants at flowering phase was 9 (men=2 and women=7) in the locality of 3 de Diciembre, and 12 (men=5, women =7) in the locality of Paca. Total number of participants at harvesting phase was 9 (men=2 and women=7) in the locality of 3 de Diciembre, and 12 (men=5, women =7) in the locality of Paca. Additionally, an organoleptic evaluation was assessed at harvesting to evaluate appearance, taste and texture. The number of panelists was 12 (men=4, women=8) and 24 (men=13, women=11) for both localities respectively.
DOI: 10.3929/ethz-b-000493708
title: Noble gases in CM carbonaceous chondrites: Effect of parent body aqueous and thermal alteration and cosmic ray exposure ages
DOI: 10.15468/dl.s6mumd
title: Occurrence Download

description: A dataset containing 419 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Arhopala amantes"
 ]
}

 The dataset includes 419 records from 16 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0003677-260126135527185/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.30009277
title: A Central Asian Food Dataset for Personalized Dietary Interventions

description: This is the first large-scale, open-access dataset of regional foods to preserve Central Asian food heritage. The modern Kazakh diet represents a combination of the traditional nomadic food culture, centered on meat and dairy products, and the current influence of dietary trends due to globalization and urbanization. Therefore, the final dataset includes 42 food categories and more than 16,000 images of national dishes that are specific to this region. The dataset can be used for food recognition and dietary assessment tasks. Beyond research, this dataset also supports the digitalization of the Central Asian cuisine, supporting the revival of the Silk Road cuisines and contributing to environmentally sustainable, socially equitable, and climate-resilient future dietary pathways in Inner Asia and the Caucasus.In case of using our dataset, please cite our work: Karabay, A., Bolatov, A., Varol, H. A., & Chan, M. Y. (2023). A Central Asian Food Dataset for Personalized Dietary Interventions. Nutrients, 15(7), 1728. https://doi.org/10.3390/nu15071728
DOI: 10.6084/m9.figshare.30009277.v3
title: A Central Asian Food Dataset for Personalized Dietary Interventions

description: This is the first large-scale, open-access dataset of regional foods to preserve Central Asian food heritage. The modern Kazakh diet represents a combination of the traditional nomadic food culture, centered on meat and dairy products, and the current influence of dietary trends due to globalization and urbanization. Therefore, the final dataset includes 42 food categories and more than 16,000 images of national dishes that are specific to this region. The dataset can be used for food recognition and dietary assessment tasks. Beyond research, this dataset also supports the digitalization of the Central Asian cuisine, supporting the revival of the Silk Road cuisines and contributing to environmentally sustainable, socially equitable, and climate-resilient future dietary pathways in Inner Asia and the Caucasus.In case of using our dataset, please cite our work: Karabay, A., Bolatov, A., Varol, H. A., & Chan, M. Y. (2023). A Central Asian Food Dataset for Personalized Dietary Interventions. Nutrients, 15(7), 1728. https://doi.org/10.3390/nu15071728